CVRX
CVRx, Inc.$1.42 +0.05 (+3.65%)
Oct 23 4:00 PM ET · prev $1.37
Market cap
$36.5M
Nano cap
Consensus
Buy
69% Buy or better · 13 analysts
Median target
$4.50
+217% · range $3.50–6.00
Next earnings
Nov 5
in 10 days · EPS est. −$0.50
1 year
−86.4%
from $10.45 · Oct 24
30 days
−43.9%
from $2.53
52-week range
$1.30–10.81
−87% from high · low Oct 16
Avg volume 20D
723.1K
Sep 30 spike 4.27M
Short interest
1.98M
≈7.4% of shares · +20.6%
Days to cover
2.4
at average volume
Insider net
+$244.1K
2 buyers · 6 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BEARISH 3 reports · 90 days
Balance 2 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 3/3 ·Next Earnings date, Nov 5, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- B Feb 20 1 insider buy $297.6K at $6.36
- S Mar 2 5 insiders sell $126.6K at $7.90
- R Apr 13 CVRx reported preliminary Q1 2026 revenue of $14.7–14.8 million (app…
- A Aug 8 Lake Street downgrades
- S Aug 12 1 insider sell $3.3K at $2.55
- B Aug 13 1 insider buy $76.4K at $2.91
- R Oct 3 Jorey Chernett, who previously held over 5.5% of CVRx and publicly c…
Signal stack
Where each data set points today.
- InsidersBULLISH
2 insiders bought $374.0K at an average $5.12. 6 insiders sold $129.9K. Price is 72% below their cost.
- InstitutionsBULLISH
Q2 2026: 15 added (0 new), 8 trimmed or exited.
- AnalystsBULLISH
9 of 13 rate it Buy or better. Every target is above the price.
- EstimatesFALLING
Current-quarter EPS estimate −$0.478 → −$0.503 over 90 days. 3 up, 2 down in 30 days.
- Short sellersBUILDING
Short interest +20.6% to 1.98M shares. 2.4 days to cover, ≈7.4% of shares.
- TrendDOWNTREND
41% below its 50-day average.
- SocialQUIET
No Reddit mentions this week. Last mention Sep 26.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| ROYAL BANK OF CANADA | ADD | $6.3M |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | ADD | $4.5M |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | $1.2M |
| UBS Group AG | DOUBLED | $1.2M |
| GOLDMAN SACHS GROUP INC | TRIM | $768.5K |
| Kestra Advisory Services, LLC | DOUBLED | $680.5K |
| DIMENSIONAL FUND ADVISORS LP | DOUBLED | $659.9K |
| Quantinno Capital Management LP | TRIM | $423.2K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
13 analysts 69% rate it Buy or better
12-month targets · 6 analysts
$1.42 $3.50 $4.50 $6.00
Price is below the lowest target. Median implies +217%.Targets as of Oct 26, 2026.
Recent actions
| Date | Firm | Rating |
|---|---|---|
| Aug 17, 2026 | Cantor Fitzgerald MAINTAIN | Overweight |
| Aug 7, 2026 | Lake Street DOWNGRADE | Hold |
Reddit
Recent posts
All social signals and their track recordsInsider ledger
Form 4$374.0K
bought · 2 insiders
$129.9K
sold · 6 insiders
−72.3%
vs their $5.12 cost
| Date | Insider | Type | Value |
|---|---|---|---|
| Aug 13, 2026 | Binkowski Brent CHIEF OPERATING OFFICER | BUY | $76.4K |
| Aug 12, 2026 | Binkowski Brent CHIEF OPERATING OFFICER | SELL | $3.3K |
| Jun 1, 2026 | Hill, Mitch C. Director | AWARD | 8,720 sh |
| Jun 1, 2026 | SHADAN MARTHA Director | AWARD | 11,182 sh |
| Jun 1, 2026 | DALE MICHAEL D Director | AWARD | 29,005 sh |
| Jun 1, 2026 | Ballinger Kevin J. Director | AWARD | 8,720 sh |
| Jun 1, 2026 | DALE MICHAEL D Director | AWARD | 36,252 sh |
| Jun 1, 2026 | SLATTERY JOSEPH P Director | AWARD | 8,720 sh |
Earnings setup
EstimatesNov 5
reports in 10 days
−$0.50
EPS estimate, this quarter
−5%
estimate change, 90 days
3↑ 2↓
revisions, 30 days
Current-quarter EPS estimate
−$0.47890d
−$0.48460d
−$0.48430d
−$0.4847d
−$0.503Now
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.50 | -$0.53–-$0.47 | -3.8% | $13.9M |
| Next Q | -$0.49 | -$0.51–-$0.46 | -5.9% | $14.4M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Congressional trades
CVRX trades disclosed by members of Congress, with disclosure delay.
1 members · 0 buys / 2 sells
| Date | Member | Type | Amount |
|---|---|---|---|
| Jul 8, 2026 | Richard Blumenthal D· SENATE· CVRX INC | SELL | $1,001 - $15,000 |
| Jul 8, 2026 | Richard Blumenthal D· SENATE· CVRX INC | SELL | $1,001 - $15,000 |
Short side
FINRA· Sep 30, 20261,982,426
shares short
+20.6%
vs prior settlement
2.4
days to cover
≈7.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
CVRx, Inc. announced it will report its Q3 2026 results on November 5, 2026.
PRESS-RELEASE — Impact 1/10
Oct 22, 2026 Earnings
Oct 2, 2026 SEC CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
MINNEAPOLIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (
Jorey Chernett, who previously held over 5.5% of CVRx and publicly called for a sale of the company, has sold…
SC 13D/A — Impact 7/10
Aug 13, 2026 Insider
Binkowski Brent bought 26,223 shares
CHIEF OPERATING OFFICER @ $2.91 ($76.4K)
Aug 12, 2026 Insider
Aug 11, 2026 SEC Binkowski Brent sold 1,309 shares
CHIEF OPERATING OFFICER @ $2.55 ($3.3K)
CVRx terminated Chief Revenue Officer Robert John effective immediately, citing a 'revised commercial outlook' and…
8-K — Impact 5/10
Jul 8, 2026 Congress
Richard Blumenthal sell
$1,001 - $15,000 — Senate
Jul 8, 2026 Congress
Richard Blumenthal sell
$1,001 - $15,000 — Senate
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Oct 22, 2026
Earnings
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
MINNEAPOLIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (
Oct 1, 2026
Press release
HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop
SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights litigation firm, announces it has opened an investigation…
Sep 30, 2026
Short interest
Short Interest: CVRX up 21% to 2.0M shares
Settlement 2026-09-30 | Days to cover: 2.40 | ≈7.44% of shares outstanding (est.)
Sep 29, 2026
Press release
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
Sep 21, 2026
Press release
CVRx Appoints John Landry as Chief Financial Officer
Landry Brings Two Decades of Medtech and Public Company Finance Experience Landry Brings Two Decades of Medtech and Public Company Finance Experience
SecBot reports
15 filings · 2 bullish · 3 bearish · 10 neutral- NEUTRAL PRESS-RELEASEOct 22, 2026
CVRx, Inc. announced it will report its Q3 2026 results on November 5, 2026.
- BEARISH SC 13D/AOct 2, 2026
Jorey Chernett, who previously held over 5.5% of CVRx and publicly called for a sale of the…
The activist who was pushing for a sale has capitulated and sold out at distressed prices (well below the $2.59 average of the first sale tranche). This removes the primary catalyst for a near-term…
- BEARISH 8-KAug 11, 2026
CVRx terminated Chief Revenue Officer Robert John effective immediately, citing a 'revised…
The CRO departure explicitly tied to commercial underperformance is a near-term negative for CVRX. Monitor for any preliminary Q3 revenue updates or guidance revisions in the coming weeks, as the…
- NEUTRAL PRESS-RELEASEJul 23, 2026
CVRx, Inc. announced it will report its Q2 2026 results on August 6, 2026.
All CVRX filing & press-release reports (15)
- PRESS-RELEASE reportOct 22, 2026
- SC 13D/A reportOct 2, 2026
- 8-K reportAug 11, 2026
- PRESS-RELEASE reportJul 23, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportJun 9, 2026
- PRESS-RELEASE reportJun 9, 2026
- 3 reportJun 3, 2026
- 8-K reportMay 11, 2026
- PRESS-RELEASE reportApr 27, 2026
- 8-K reportApr 13, 2026
- DEFA14A reportApr 20, 2026
- CLUSTER reportMar 2, 2026
- CLUSTER reportMar 2, 2026
- CLUSTER reportMar 2, 2026